Scl specifies hemogenic endothelium and inhibits cardiogenesis via primed enhancers [ChIP-seq]
Ontology highlight
ABSTRACT: Scl/Tal1 confers hemogenic competence and prevents cardiomyogenesis in embryonic endothelium. Here we show that Scl both directly activates a broad gene regulatory network required for hematopoietic stem/progenitor cell (HS/PC) development, and represses transcriptional regulators required for cardiogenesis. Cardiac repression occurs during a short developmental window through Scl binding to distant cardiac enhancers that harbor H3K4me1 at this stage. Scl binding to hematopoietic regulators extends throughout HS/PC and erythroid development and spreads from distant enhancers to promoters. Surprisingly, Scl complex partners Gata 1 and 2 are dispensable for hematopoietic versus cardiac specification and Scl binding to the majority of its target genes. Nevertheless, Gata factors co-operate wi
ORGANISM(S): Mus musculus
SUBMITTER: Tõnis Org
PROVIDER: E-GEOD-47082 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA